EFESA
BRANDED
Efesa contains Efepoetin alpha (recombinant human erythropoietin-hybrid Fc fusion protein) which is a recombinant compound between two human erythropoietin molecules and hybrid FC region (hyFC®) fragment. It has advantages of low immunogenicity and longer half-life.